Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials. [electronic resource]
- PloS one 2014
- e90028 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural